Global Research Needle-Free Injectors Market Key Players, Trends, | Page 2

Alone in the U.S. millions of dollars are spent on hypodermic needles used for children. Also, due to the inflated costs
of hypodermic needles a lower rate of vaccination is gained in the developing countries. Another drawback is hygiene.
If the needle is not sterilized properly, reuse can be a major problem resulting into spread of contagious diseases.
Hence, with the use of needle-free systems all the above mentioned drawbacks can be overcome and a higher rate of
vaccination can be achieved in the developing countries.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/needle-free-injectors-market/request-sample
Commercially, the needle-free injectors market is expected to grow at a higher CAGR owing to extensive R&D in the
vaccine industry and the route of medicine administration. Therefore, the market is bound to grow significantly for
the assessment period.
See More Reports of This Category by Million Insights @
https://www.millioninsights.com/industry/medical-devices
Market Segment:
This report studies Needle-free Injectors in Global market, especially in North America, Europe, China, Japan,
Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and
market share for each manufacturer, covering
• Bayer AG
• Sanofi
• Amedra Pharmaceuticals
• ALK Abello
• Novartis International AG
• Unilife Corporation
• Pfizer